Delivery Order SPE2DB20D3103-SPE2DB22FM4D0

Award Date 1/25/22
Potential Completion Date 1/26/22
Potential Value $67K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,343.11 firm fixed-price delivery order is for TRIUMEQ 600-50-300 MG TABLET. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., which runs through November 2026. The IDC serves as the primary vehicle for Amerisourcebergen...
This is a $116,388.29 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract provides the DLA with TRIUMEQ 600-50-300 MG TABLET, a specialty pharmaceutical product, through January 27, 2025. This award is a task order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, valued at $51,769.82, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, with an ultimate completion date of November 21, 2023. The contract provides Triumeq 600-50-300 mg tablets to support military and federal healthcare programs. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award, valued at $9,874.75, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of Triumeq 600-50-300 mg tablets, a prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $36,283.96, is for the procurement of Triumeq 600-50-300 mg tablets to support military healthcare programs. The contract is a firm fixed-price, delivery order type with an ultimate completion date of December 30, 2024. There is no set-aside designation indicated for this award....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $13,039.74 firm fixed-price delivery order is for TRIUMEQ 600-50-300 MG TABLET prescription medication. The contract has an ultimate completion date of January 3, 2025. The award is associated with a larger Indefinite Delivery Contract (IDC) worth $999,999,999 that Amerisourcebergen holds with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $93,942.54 firm fixed-price delivery order is for the supply of Triumeq 600-50-300 mg tablets. The award is not associated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026. This IDC serves as...
This federal contract award is for the delivery of TRIUMEQ 600-50-300 MG TABLET medication to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $11,496.12 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 10, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a key vendor for federal...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $13,039.74, and has an ultimate completion date of January 21, 2025. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) held by...
This is a $12,199.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the supply of TRIUMEQ 600-50-300 MG TABLET, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 14, 2023 and was awarded on November 13, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB22FM4D0
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $67,089.96 firm fixed-price delivery order is for the supply of Triumeq 600-50-300 mg tablets. The contract has an ultimate completion date of January 26, 2022 and was awarded on January 25, 2022. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical through December 31, 2025. The IDC enables the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. No set-aside designation was used for this contract award.

Generated 2/27/25, 12:49 PM